NYSE
115.41USD
-0.92 (-0.79%)
We have scored 30 news catalysts on Aflac Incorporated (AFL) over the past 12 months. The biggest single-day move next to one of them came Aug 9, 2026, when AFL closed −1.6%: “Aflac: Reliable Dividend Compounder, Premium Justified, But Meaningful Upside Unlikely”. Coverage across the window leans positive (average ticker sentiment +0.24). Most of the impact sits in sector financials and institutional appeal.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
58.6B
P/E
—
EPS
—
Beta
0.58
52W range
105.43-130.22
Day range
115.25–116.50
Open
116.41
Prev close
116.33
Volume
887.2K
Avg volume
2.4M
Dividend
2.41
IPO
1980-03-17
Analysts publish price targets on AFL, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
8 analyst price targets from $108 to $138
as of 2026-09-02
The market is within 6% of the median target — broadly agreeing with the analysts.
The reconstruction
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Aflac Incorporated — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for AFL: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.
At $115, the stock sits at the 38th percentile of the eight published analyst models, meaning the market broadly agrees with the middle of the street but refuses to pay for the most optimistic growth scenario.
What the disagreement turns on
Can Japan's new-product premium growth actually accelerate fast enough to offset currency headwinds and deliver the 8.1% revenue growth the current price requires, and unit volume data is the only wired measurement that can test it.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
